AMRI
- PharmAssess™ GMP Audit
About Albany Molecular Research, Inc. (AMRI)
Founded in 1991 as Albany Molecular Research, Inc., AMRI (NASDAQ: AMRI) provides scientific services, products and technologies focused on improving the quality of life. The company has steadily evolved, with global facilities now in the United States, Europe and Asia. Its 1,200+ employees have the experience and commitment necessary to provide customers with a wide range of services, technologies and cost models.
AMRI performs services including drug discovery, pharmaceutical development, and manufacturing of active ingredients and pharmaceutical intermediates for many of the world's leading healthcare companies.
A separate, stand alone R&D division of the company is also developing technology that it intends to partner and outlicense, an area often viewed as a higher value added service to the many companies with which AMRI is working.
About the Audit
The audit on AMRI Inc was performed on 21 – 22 September 2008. The Report is 41 pages long, excluding appendices. Including appendices the Report is 77 pages long.
The Audit Report provides information on the site facilities and covers a wide range of materials, including; Furosemide, Atenolol, Chlorpheniraminemaleate, Mebendazole, Warfarin Sodium, Metroprolol Tartarate, Metfromin Hydrochloride, Miconazole Nitrate.
How to Purchase an Audit
Once you have decided which PharmAssess™ audit report(s) you require, purchasing a report is very simple:
- A quotation will be sent to you for the purchase of the Audit Report(s) you require.
- Rephine obtains auditee's approval for sale of the report.
- Once approval of the Quotation is received we will dispatch the Audit Report, in CD format accompanied by an Invoice.
- On receipt of payment the password to access the report is immediately issued
Purchase this Audit »
Ad-Hoc Audit Requirements
Please note that if there are other audits that you require, which are not in the PharmAssess Section of this website, please contact us to discuss your audit requirements, which we can undertake on your behalf.
Rephine has an ongoing programme of audits which is being constantly updated. If an audit you require is not on the list of those available, please contact the Rephine office to establish whether it is in the programme to be done or how it can be fitted in to the programme.
Commissioned GMP Auditing »
Further Information
If you require further information about the PharmAssess™ services offered by Rephine, or you would like to purchase an Audit Report, please contact us by email at enquiries@rephine.com or telephone 0044 1763 853135